Changeflow GovPing Healthcare & Life Sciences Methods of Creating and Screening DNA-Encoded L...
Routine Notice Added Final

Methods of Creating and Screening DNA-Encoded Libraries

Favicon for changeflow.com USPTO Patent Grants - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO granted Patent US12606817B2 to X-Chem, Inc. (inventor: Richard W. Wagner) for methods of creating and screening DNA-encoded libraries for drug discovery applications. The patent contains 17 claims covering synthesis and screening methodologies that link functional moieties to initiator oligonucleotides for target binding identification. The filing date was June 19, 2020, with application number 16906626.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

X-Chem, Inc. received USPTO Patent US12606817B2 for methods of identifying compounds that bind to biological targets using DNA-encoded libraries. The patented methods involve synthesizing libraries where compounds contain functional moieties with diversity positions, operatively linked to initiator oligonucleotides that identify compound structures. This is a standard biotech patent grant strengthening X-Chem's intellectual property position in DNA-encoded library technology.

Competitors developing DNA-encoded library screening methods should conduct freedom-to-operate analyses to assess potential infringement exposure. Pharmaceutical and biotechnology companies utilizing these techniques may need to evaluate licensing requirements or design-around strategies for drug discovery programs leveraging similar approaches.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Methods of creating and screening DNA-encoded libraries

Grant US12606817B2 Kind: B2 Apr 21, 2026

Assignee

X-Chem, Inc.

Inventors

Richard W. Wagner

Abstract

The present invention features a number of methods for identifying one or more compounds that bind to a biological target. The methods include synthesizing a library of compounds, wherein the compounds contain a functional moiety having one or more diversity positions. The functional moiety of the compounds is operatively linked to an initiator oligonucleotide that identifies the structure of the functional moiety.

CPC Classifications

C07H 21/00 C12N 15/1065 C12N 15/1068 C12Q 1/6809 C40B 20/04 C40B 40/04 C40B 40/06 C40B 40/08 C40B 50/06 C40B 70/00

Filing Date

2020-06-19

Application No.

16906626

Claims

17

View original document →

Get daily alerts for USPTO Patent Grants - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12606817B2

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Drug discovery methods Biotech IP
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!